Autor: venred

THOUSAND OAKS, Calif., Jan. 11, 2021 /PRNewswire/ — Amgen (NASDAQ: AMGN) today announced the launch of a new seven-year environmental sustainability plan, which includes a commitment to achieve carbon neutrality, while also reducing water use by 40% and waste disposed by 75%.

«As a science-based company with a mission to serve patients, we understand the profound impact that climate change is having on human health around the world,» said Robert A. Bradway, chairman and chief executive officer at Amgen.  «Our new commitments expand on our previous achievements and drive Amgen’s continued leadership on environmental sustainability that will benefit our patients, staff, shareholders and communities.»

Since 2007, Amgen has implemented projects resulting in a 33% reduction in carbon emissions, a 30% reduction in water use and a 28% reduction in waste. These reductions were achieved even as the company increased production capacity, expanded our presence to more than 100 countries and grew revenues significantly.

Amgen will invest more than $200 million to achieve these 2027 environmental commitments, and expects that such investment will help us to become not just more environmentally sustainable but also more flexible and productive, resulting in reductions in operating costs from such efficiencies over the same period. The company will focus on the use of innovative technologies to significantly reduce carbon emissions from Amgen-owned operations, as well as on sourcing renewable energy. For example, Amgen’s newest biomanufacturing plant in Singapore generates 70% less carbon than traditional biomanufacturing facilities. The company has built a second such plant in Rhode Island.

Where carbon emissions cannot be eliminated from its operations, Amgen will invest in sustainability projects that sequester or avoid greenhouse gas emissions. In addition, Amgen will engage with its suppliers to assist and encourage carbon reductions throughout its value chain.

More information about Amgen’s environmental plans can be found here.

About Amgen
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. 

For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.

Forward-Looking Statements
This news release contains forward-looking statements that are based on the current expectations and beliefs of Amgen. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including any statements on the outcome, benefits and synergies of collaborations, or potential collaborations, with any other company, including Adaptive Biotechnologies (including statements regarding such collaboration’s ability to discover and develop fully-human neutralizing antibodies targeting SARS-CoV-2 to potentially prevent or treat COVID-19), BeiGene, Ltd., or the Otezla acquisition, including anticipated Otezla sales growth and the timing of non-GAAP EPS accretion, as well as estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes, effects of pandemics or other widespread health problems such as the ongoing COVID-19 pandemic on our business, outcomes, progress, or effects relating to studies of Otezla as a potential treatment for COVID-19, and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission reports filed by Amgen, including our most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and current reports on Form 8-K. Unless otherwise noted, Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.

No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Our results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments involving current and future products, sales growth of recently launched products, competition from other products including biosimilars, difficulties or delays in manufacturing our products and global economic conditions. In addition, sales of our products are affected by pricing pressure, political and public scrutiny and reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. We or others could identify safety, side effects or manufacturing problems with our products, including our devices, after they are on the market. Our business may be impacted by government investigations, litigation and product liability claims. In addition, our business may be impacted by the adoption of new tax legislation or exposure to additional tax liabilities. If we fail to meet the compliance obligations in the corporate integrity agreement between us and the U.S. government, we could become subject to significant sanctions. Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors, or we may fail to prevail in present and future intellectual property litigation. We perform a substantial amount of our commercial manufacturing activities at a few key facilities, including in Puerto Rico, and also depend on third parties for a portion of our manufacturing activities, and limits on supply may constrain sales of certain of our current products and product candidate development. An outbreak of disease or similar public health threat, such as COVID-19, and the public and governmental effort to mitigate against the spread of such disease, could have a significant adverse effect on the supply of materials for our manufacturing activities, the distribution of our products, the commercialization of our product candidates, and our clinical trial operations, and any such events may have a material adverse effect on our product development, product sales, business and results of operations. We rely on collaborations with third parties for the development of some of our product candidates and for the commercialization and sales of some of our commercial products. In addition, we compete with other companies with respect to many of our marketed products as well as for the discovery and development of new products. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, some raw materials, medical devices and component parts for our products are supplied by sole third-party suppliers. Certain of our distributors, customers and payers have substantial purchasing leverage in their dealings with us. The discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. Our efforts to collaborate with or acquire other companies, products or technology, and to integrate the operations of companies or to support the products or technology we have acquired, may not be successful. A breakdown, cyberattack or information security breach could compromise the confidentiality, integrity and availability of our systems and our data. Our stock price is volatile and may be affected by a number of events. Our business performance could affect or limit the ability of our Board of Directors to declare a dividend or our ability to pay a dividend or repurchase our common stock. We may not be able to access the capital and credit markets on terms that are favorable to us, or at all.

CONTACT: Amgen, Thousand Oaks
Megan Fox, 805-447-1423 (media)
Trish Rowland, 805-447-5631 (media)
Arvind Sood, 805-447-1060 (investors)

View original content to download multimedia:http://www.prnewswire.com/news-releases/amgen-to-achieve-carbon-neutrality-by-2027-301205666.html

SOURCE Amgen

ATLANTA, Jan. 11, 2021 /PRNewswire/ — Since the outbreak of the COVID-19 pandemic, Georgia Power and Southern Nuclear have made significant adjustments to work practices at the Plant Vogtle Units 3 and 4 project site, designed to protect the health and safety of the project workforce and the surrounding community while maintaining productivity. Since October, the site has seen a significant increase in COVID-19 cases, consistent with the broader regional and national rise in cases. This increase, combined with other productivity challenges, continues to impact construction production and the pace of testing activity completion.

As a result, the project team is analyzing the schedule for key milestones, including the start of hot functional testing and fuel load for Unit 3, and expects to adjust those dates. Georgia Power continues to expect to meet its commitment to achieve the November 2021 and 2022 regulatory-approved in-service dates for Units 3 and 4, respectively. Further updates will be provided in connection with the Southern Company quarterly earnings call in February 2021.

About Georgia Power
Georgia Power is the largest electric subsidiary of Southern Company (NYSE: SO), America’s premier energy company. Value, Reliability, Customer Service and Stewardship are the cornerstones of the company’s promise to 2.6 million customers in all but four of Georgia’s 159 counties. Committed to delivering clean, safe, reliable and affordable energy at rates below the national average, Georgia Power maintains a diverse, innovative generation mix that includes nuclear, coal and natural gas, as well as renewables such as solar, hydroelectric and wind. Georgia Power focuses on delivering world-class service to its customers every day and the company is recognized by J.D. Power as an industry leader in customer satisfaction. For more information, visit www.GeorgiaPower.com and connect with the company on Facebook (Facebook.com/GeorgiaPower), Twitter (Twitter.com/GeorgiaPower) and Instagram (Instagram.com/ga_power).

Cautionary Note Regarding Forward-Looking Statements
Certain information contained in this release is forward-looking information based on current expectations and plans that involve risks and uncertainties. Forward-looking information includes, among other things, statements concerning the expected schedule for completion of construction and start-up of Plant Vogtle Units 3 and 4. Georgia Power cautions that there are certain factors that can cause actual results to differ materially from the forward-looking information that has been provided. The reader is cautioned not to put undue reliance on this forward-looking information, which is not a guarantee of future performance and is subject to a number of uncertainties and other factors, many of which are outside the control of Georgia Power; accordingly, there can be no assurance that such suggested results will be realized. The following factors, in addition to those discussed in Georgia Power’s Annual Report on Form 10-K for the year ended December 31, 2019, Quarterly Reports on Form 10-Q for the quarters ended March 31, 2020, June 30, 2020, and September 30, 2020, and subsequent securities filings, could cause actual results to differ materially from management expectations as suggested by such forward-looking information: the potential effects of the continued COVID-19 pandemic, including, but not limited to, extended disruptions to supply chains and further reduced labor availability and productivity, which could have a variety of adverse impacts, including a negative impact on the ability to develop, construct, and operate facilities, including, but not limited to, Plant Vogtle Units 3 and 4; the ability to control costs and avoid cost and schedule overruns during the development, construction, and operation of facilities or other projects, including Plant Vogtle Units 3 and 4, which includes components based on new technology that only within the last few years began initial operation in the global nuclear industry at this scale, and including changes in labor costs, availability and productivity, challenges with management of contractors or vendors, subcontractor performance, adverse weather conditions, shortages, delays, increased costs, or inconsistent quality of equipment, materials, and labor, contractor or supplier delay, delays due to judicial or regulatory action, nonperformance under construction, operating, or other agreements, operational readiness, including specialized operator training and required site safety programs, engineering or design problems, design and other licensing-based compliance matters, including, for nuclear units, the timely submittal by Southern Nuclear of the Inspections, Tests, Analyses, and Acceptance Criteria documentation for each unit and the related reviews and approvals by the U.S Nuclear Regulatory Commission (the «NRC») necessary to support NRC authorization to load fuel, challenges with start-up activities, including major equipment failure, or system integration, and/or operational performance; the ability to overcome or mitigate the current challenges at Plant Vogtle Units 3 and 4, including, but not limited to, those related to COVID-19, that could further impact the cost and schedule for the project; legal proceedings and regulatory approvals and actions related to construction projects, such as Plant Vogtle Units 3 and 4, including Public Service Commission approvals and NRC actions; under certain specified circumstances, a decision by holders of more than 10% of the ownership interests of Plant Vogtle Units 3 and 4 not to proceed with construction and the ability of other Vogtle owners to tender a portion of their ownership interests to Georgia Power following certain construction cost increases; the ability to construct facilities in accordance with the requirements of permits and licenses (including satisfaction of NRC requirements), to satisfy any environmental performance standards and the requirements of tax credits and other incentives, and to integrate facilities into the Southern Company system upon completion of construction; the inherent risks involved in operating and constructing nuclear generating facilities; the ability of counterparties of Georgia Power to make payments as and when due and to perform as required; the direct or indirect effect on Georgia Power’s business resulting from cyber intrusion or physical attack and the threat of physical attacks; catastrophic events such as fires, earthquakes, explosions, floods, tornadoes, hurricanes and other storms, droughts, pandemic health events or other similar occurrences; and the direct or indirect effects on Georgia Power’s business resulting from incidents affecting the U.S. electric grid or operation of generating or storage resources. Georgia Power expressly disclaims any obligation to update any forward–looking information.

View original content to download multimedia:http://www.prnewswire.com/news-releases/georgia-power-expects-to-adjust-key-milestones-at-plant-vogtle-301205636.html

SOURCE Georgia Power

WASHINGTON, Jan. 11, 2021 /PRNewswire/ — A coalition of young, diverse voters delivered two Democratic Senate seats in Georgia, which has one of the fastest-growing Latinx populations in the country. Voto Latino, the nation’s leading Latinx voter registration outfit, registered 11,528 Georgian voters between November 30 and December 7 for the January 5 Senate runoff. Voto Latino previously registered 35,787 Georgians for the 2020 general election cycle, in which Biden won by 11,779 votes.

«Georgians’ unprecedented turnout in a runoff election demonstrates that long term investments in community organizing are effective, and that every vote does matter,» said María Teresa Kumar, president and CEO of Voto Latino. «This is Voto Latino’s third Georgia election, and our wins could not have been possible without our volunteers, community partners, and the steadfast leadership of Stacey Abrams and Lauren Groh-Wargo of Fair Fight.»

TargetSmart estimates that at least 74,487 Latinx voters voted early for the runoff election – 64% of the November 2020 early vote total and 180% more than the Latinx early vote total in 2016. In the midterm election of 2018, approximately 10% of Latinx voters turned out. This year, that number could be as high as 65%, exceeding all expectations and capping off a wave of Latinx voter engagement throughout the country during this election cycle.

This special election concludes Voto Latino’s record-breaking investment in Latinx political empowerment for the 2020 cycle. After close to a decade of organizing in many of these states, a $34.2 million dollar effort, Voto Latino registered 601,330 voters in Arizona, Texas, Georgia, Nevada, North Carolina, Wisconsin, Colorado, and Florida, and mobilized 3.7 million low propensity voters to the polls. This cycle, Voto Latino’s work helped flip Arizona and Georgia, defended Nevada and Wisconsin, sent four new Senators to Washington, and turned Texas and North Carolina purple, demonstrating the overwhelming contribution Latinx voters in the South made to deliver the White House.

For the Georgia effort, Voto Latino partnered with local organizations within the state for a host of election-related activities. Voto Latino’s partners included Fair Fight, La Borinqueña, Athens AntiDiscrimination Movement (AADM), Blueprint 58 Atlanta, Georgia League of Women Voters, Georgia Muslim Voter Project, Georgia Sierra Club, Mijente, New Georgia Project, Pro Georgia, Southerners on New Ground (SONG), State Voices, Students for Tomorrow, and the Trans Queer Liberation Movement.

Through Voto Latino’s numerous local partnerships, it co-hosted virtual text banks and organized events, such as a Fuse TV Townhall with board members Rosario Dawson and Wilmer Valderamma. VL Impact Council Co-Chair Zoe Saldana also contributed to the effort. The Georgia program included texting 95,000 young voters of color, providing media training to 33 volunteers, collaboratively sending 1,140 handwritten letters to voters, providing thousands of rides to the polls through Lyft, and uplifting the work of numerous local organizations.

Voto Latino is a grassroots political organization focused on educating and empowering a new generation of Latinx voters, as well as creating a more robust and inclusive democracy. Through innovative digital campaigns, culturally relevant programs and authentic voices, we shepherd the Latinx community towards the full realization of its political power. 

Contact:
Danny Turkel, danny@votolatino.org

View original content to download multimedia:http://www.prnewswire.com/news-releases/newly-registered-latinx-voters-key-to-georgia-runoff-victory-voto-latino-registered-15-of-all-new-georgia-voters-since-general-election-301205651.html

SOURCE Voto Latino

PHOENIX, Jan. 11, 2021 /PRNewswire/ — Republic Services, Inc. (NYSE: RSG) today announced that it will release its fourth quarter 2020 financial results on Monday, Feb. 22, 2021, after the market closes, and will host an investor conference call at 5 p.m. ET. A live audio webcast of the conference call can be accessed by logging onto the Company’s Investor Relations page on republicservices.com, or listeners may access the call by dialing 844-890-1789 or 412-717-9598, passcode Republic Services.

The Company encourages participants who will be dialing in to pre-register for the conference call using the following link: https://dpregister.com/sreg/10150722/dfb6f25a04. Callers who pre-register will be given a conference passcode and PIN to gain immediate access to the call and bypass the live operator on the day of the call. Participants may pre-register at any time, including up to and after the call start time.

A replay of the call will be available one hour after the end of the conference through March  1, 2021, by calling 877-344-7529 or 412-317-0088, passcode 10150722. The conference call will also be archived on the Company’s website at republicservices.com.

About Republic Services
Republic Services, Inc. is an industry leader in U.S. recycling and non-hazardous solid waste disposal. Through its subsidiaries, Republic’s collection companies, transfer stations, recycling centers, landfills and environmental services provide effective solutions to make responsible recycling and waste disposal effortless for its customers across the country. Its 36,000 employees are committed to providing a superior experience while fostering a sustainable Blue Planet® for future generations to enjoy a cleaner, safer and healthier world. For more information, visit RepublicServices.com, or follow us at Facebook.com/RepublicServices, @RepublicService on Twitter and @republic_services on Instagram.

The Company participates in investor presentations and conferences throughout the year. Interested parties can find a schedule of these conferences at republicservices.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/republic-services-inc-sets-date-for-fourth-quarter-2020-earnings-release-and-conference-call-301205331.html

SOURCE Republic Services, Inc.